Recent Finacing
Recent Raise
EVS Glaucoma Therapeutics, a Herndon spinout of Euclid Vision Systems, develops an implantable, biodegradable collagen-based sustained-release device to deliver latanoprost for glaucoma treatment.
Focus Areas
Recent Investors
Funding round
Investor